Article
Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review
1 Sept 2019
Abstract excerpt
Nearly half of patients with colorectal cancer (CRC), the third leading cause of cancer deaths worldwide, are diagnosed in the late stages of the disease. Appropriate treatment is not applied in a timely manner and nearly 90% of the patients who experience metastasis ultimately die. Timely detection of CRC can increase the five-year survival rate of patients. Existing histopathological and molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
